Great find zecs.
They have known this since 1/12/22 it seems. It would be interesting to know why they would have trouble recruiting participants if they had multiple drug resistant infections. I would surely assume it is because of discomfort or pain on application.
at least we know there was a problem and no big secret of it working but holding the information. I guess it just confirms what will happen if there are any issues with uti or other trials. On the positive side now looking VERY good for the foot ulcer trials.RecruitmentRecruitment statusStopped earlyData analysisData analysis is completeReason for early stopping/withdrawalParticipant recruitment difficultiesDate of first participant enrolmentAnticipated1/06/2021Actual20/09/2021Date of last participant enrolmentAnticipated1/12/2022Actual27/04/2022Date of last data collectionAnticipated31/12/2022Actual18/05/2022Sample sizeTarget30
- Forums
- ASX - By Stock
- Ann: Positive Patients Update - Special Access Scheme
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

Great find zecs.They have known this since 1/12/22 it seems. It...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 28921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 0.305 |
4 | 17833 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 28921 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online